… role in the differentiation of stem cells into cardiomyocytes (218). A proposed role for miR-208
in diabetic heart disease … of the diabetic heart which involves both left and right ventricular …

… of left ventricular ( LV ) involvement and characterized the … right ventricular cardiomyopathy
( ARVC ). Differential diagnosis between ARVC ‐ LV phenotype and dilated cardiomyopathy ( …

… together, these findings suggest the important role of endothelial dysfunction in diabetic
cardiomyopathy, and ROS inhibition may be a therapeutic target for diabetic cardiomyopathy. …

… multiple intracellular pathways involved in the pathogenesis of diabetic cardiomyopathy and
… of diabetic cardiomyopathy and heart failure in type 1 and type 2 diabetes mellitus, and we …

… and right ventricles from patients with ischemic heart disease (164). With regard to the possible
involvement of MAO in diabetes, … MAO involvement in diabetes-induced complications. …

… role of oxidative stress to diabetic heart disease (in both T1D and T2D). Similar evidence for
a causal role in clinical settings of diabetic cardiomyopathy is … with right ventricular failure. Of …

… of diabetic cardiomyopathy in a model of type 1 diabetes (T1D) in vivo. Diabetes was …
The right ventricle weight was reduced overall by diabetes (P = 0.002) and was significantly …

… , diabetic individuals are predisposed to develop a specific cardiomyopathy, termed diabetic
cardiomyopathy (… and functional damage of diabetic myocardium that occurs independent of …

… causal role of oxidative stress in diabetic heart disease is supported by antioxidant interventions
to scavenge ROS, which limit or prevent cardiac dysfunction in animal models of DM [[27…

… , molecular mechanisms and cell biology of diabetic cardiac fibrosis and proposes
therapeutic targets that may attenuate the fibrotic response, preventing heart failure progression. …